Alector (ALEC) EBIT Margin Growth (3y) (2021 - 2026)
Alector (ALEC) EBIT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Alector | 166.99 Mn | -39.52 Mn | - | -207,949.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -207,949.00 |
| Dec 31, 2025 | -25,046.00 |
| Sep 30, 2025 | -83,213.00 |
| Jun 30, 2025 | -44,542.00 |
| Mar 31, 2025 | -103,624.00 |
| Dec 31, 2024 | 38,487.00 |
| Sep 30, 2024 | -38,495.00 |
| Jun 30, 2024 | 53,997.00 |
| Mar 31, 2024 | 100,564.00 |
| Dec 31, 2023 | 77,473.00 |
| Sep 30, 2023 | 35,507.00 |
| Jun 30, 2023 | 146,330.00 |
| Mar 31, 2023 | 28,395.00 |
| Dec 31, 2022 | 15,502.00 |
| Sep 30, 2022 | 94,516.00 |
| Jun 30, 2022 | 40,441.00 |
| Mar 31, 2022 | 19,012.00 |
| Dec 31, 2021 | -19,029.00 |
| Sep 30, 2021 | 32,783.00 |
| Jun 30, 2021 | -67,029.00 |